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Glucocorticoids are potent regulators of the innate immune response, and alteration in this inhibitory feedback has
detrimental consequences for the neural tissue. This study profiled and investigated functionally candidate genes mediating
this switch between cell survival and death during an acute inflammatory reaction subsequent to the absence of
glucocorticoid signaling. Oligonucleotide microarray analysis revealed that following lipopolysaccharide (LPS) intracerebral
administration at striatum level, more modulated genes presented transcription impairment than exacerbation upon
glucocorticoid receptor blockage. Among impaired genes we identified ceruloplasmin (Cp), which plays a key role in iron
metabolism and is implicated in a neurodegenative disease. Microglial and endothelial induction of Cp is a natural
neuroprotective mechanism during inflammation, because Cp-deficient mice exhibited increased iron accumulation and
demyelination when exposed to LPS and neurovascular reactivity to pneumococcal meningitis. This study has identified genes
that can play a critical role in programming the innate immune response, helping to clarify the mechanisms leading to
protection or damage during inflammatory conditions in the CNS.
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INTRODUCTION
The presence of infection is recognized by receptors for specific
elements called the pathogen-associated molecular patterns
(PAMPs) that are produced by microorganisms. Recognition of
these PAMPs by antigen-presenting cells is the first step of
a complex inflammatory reaction that characterizes the innate
immune response [1]. Lipopolysaccharide (LPS), a major compo-
nent of the outer membranes of Gram-negative bacteria, is the
best-known target of innate recognition and induces a robust
inflammatory response by antigen-presenting cells. The endotoxin
activates a transient innate immune reaction via Toll-like receptor
4 (TLR4) and the rapid interaction of its Toll/IL-1R homology
domain with myeloid differentiation factor 88 [2,3]. This leads to
downstream signaling that activates NF-kB, a critical player in
transcriptional activation of numerous pro-inflammatory genes
[4]. Interaction of LPS with its cognate TLR4 can also activate
interferon pathway through other adaptor and signaling molecules
[1]. Collectively, these signaling events and transcriptional
processes are essential for eliminating pathogens and preparing
the transfer to a more specific acquired immune response.
Glucocorticoids (GCs) are potent endogenous anti-inflammato-
ry molecules. Activated GC receptors (GRs) are able to interfere
with the transactivation potential of the p65 NF-kB subunit as well
as AP-1. Other mechanisms explaining the effects of GCs on gene
transcription have been proposed, including the competition
between GRs and NF-kB for nuclear coactivators, such as CREB-
binding protein and p300 (CBP/p300) [5]. The mechanisms
involved in the effects of GCs on gene expression in the central
nervous system (CNS) remains largely unknown [6].
Intracerebral LPS administration causes a strong and time-
dependent transcriptional activation of inflammatory genes in
microglial cells ipsilateral to the site of injection and this acute
reaction is not associated with neuronal damage or demyelination
[7,8]. However, the inflammatory response lasts longer in the
brain of animals that are treated with the GR antagonist RU486
before the endotoxin, which then becomes highly toxic to neural
cells [9,10]. These data provide evidence that without a proper
inhibitory feedback by GCs, an acute inflammatory response may
have serious detrimental consequences for the brain.
Here we aimed to determine the genes that are differentially
regulated by LPS in the presence or absence of the GR signaling.
We took advantage of this unique in vivo model to identify the key
players involved in the delicate balance between cell survival and
death during a natural innate immune reaction in the CNS. While
the use of neurotoxins is limited to access the contribution of the
innate immunity to brain damage due to either direct or indirect
microglia activation by their ability to cause neuronal death, the
model used in the present study is unique and appropriated in this
regard. The comparison between LPS alone and LPS combined to
RU486offersanadequate paradigmbecausethederegulatedinnate
immune reaction is directly responsible for the cell fate. Functional
analysis of the differentially regulated genes between the two
conditions led to the selection of ceruloplasmin (Cp) as a candidate
protective gene and to the investigation of its role in neuroin-
flammatory contexts, providing a model to illustrate the beneficial
mechanisms engaged by the CNS innate immune response.
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Functional analysis of the differential
neuroinflammatory gene expression in presence or
absence of endogenous GCs
Our design allowed the detection of 345 probe sets representing
286 different genes (gene IDs) significantly modulated 12 h after
intrastriatal LPS injection in the ipsilateral side of the injection (no
significant changes were observed in contralateral side). These
probes are listed in the dataset S1. The 12 h time-point was
selected to avoid early gene expression noise caused by mechanical
damage and late confounding patterns originating from potential
damage subsequent to the LPS/RU486 treatment. Approximately
86.3% of the genes modulated by LPS were upregulated while
,14.7% were downregulated. Among the upregulated genes,
many were linked to the inflammatory signaling. In addition to
these expected data, genes induced by LPS in CNS are linked to
various biological processes that range from acute-phase response
to cell differentiation and angiogenesis. Downregulated genes by
the endotoxin included mainly transcription factors and those
encoding proteins related to brain development, metabolism,
myelination and transport. This information can be found in
figure 2, dataset S1 and figure S1.
Regarding gene expression comparing LPS effects in presence or
absence of RU486, 235 probe sets (representing 200 different gene
IDs) were selected according to our strategy (listed in dataset S2). It
should be noted that these probe sets do not overlap with genes that
are modulated by RU486 independently of LPS and/or side effect
interactions (GR-blockage main effect; 47 probe sets-see figure S1
C). As depicted by the figure 1D (ipsilateral side), most genes
differently expressed when evaluating the effect of RU486 on LPS-
treatment (LPS/RU486–LPS contrast) were those wherein LPS
upregulation was prevented (or partially prevented in at least 50%)
by GR blockage. This gene subset represents approximately 54.9%
of the LPS modulated genes (upregulated and downregulated). In
general,geneswithsuchbehaviorwerefoundacrossmanycategories
of biological processes (Fig. 2). Unexpectedly, genes related to host
response against pathogens and remarkably, viral and interferon
response, were also upregulated by LPS in a manner that is
prevented by RU486 (see also figure S1 A, B).
In contrast, only 18 genes presented a GR-mediated repression
on LPS-induced gene expression, many of them detected as
differently expressed in the contralateral side (Fig. 1E). These
genes can be divided into: a) those already upregulated by LPS,
such as chemokines, cytokines, JAK-STAT pathway, regulators of
transcription and others; b) genes only induced when LPS is
combined to RU486, namely a cell-surface antigen of activated
dendritic cell (Cd83), a GTPase of the RGK family (Gem) and
a transcription factor of the CNC-bZip family (Bach1).
Similarly to the transcripts that were upregulated following LPS
administration, RU486 prevented the dowregulation of 25 out of
42 genes, implying that endogenous GCs are required for both
upregulation and downregulation of a considerable number of
genes. A comprehensive exploration of microarray data is
illustrated by the figure S1 (A–F), while figure 2 shows the main
findings related to biological process according to Gene Ontology
(GO) classification.
Validation and anatomical distribution of
representative genes modulated by GR and LPS
signaling in the CNS
Several genes were selected for validation by in situ hybridization
according to transcript behavior and functional relevance. These
included acute-phase reactants (APRs) (Saa3, Lcn2 and Serpi-
na3n), genes with GR-mediated repression on LPS induction
(Gem, Cd83 and Tnfsf9) and other transcripts modulated by GR
signaling. In this particular case, RU486 essentially prevented
gene upregulation (Cd44, Stat1, Ch25h and Il1b) or down-
regulation (C1qa and Hexb) by LPS. Figure 3A shows represen-
tative examples of Saa3, Lcn2 (N-GAL/24p3), Serpina3n, Gem,
Cd83 and Tnfsf9 (4-1BBL) transcripts in the dorsal basal ganglia of
mice that received saline injection, LPS or LPS/RU486; wherein
the different pattern of expression is quite evident among
transcripts. Interestingly, Gem expression localized over cells
lining the meninges, while Cd83 and Tnfsf9 transcripts were
distributed across parenchymal elements of the brain. Moreover,
Cd83 shows convincing constitutive neuronal expression (Fig. 3A).
Figure 3B illustrates the dose-dependent effect of RU486 on brain
reaction to LPS.
Figure 4 depicts results for the validation of Cd44, Stat1,
Ch25h, Il1b, C1qa and Hexb. The anatomical distribution of
Cd44 (probed for the five first exons) and Ch25h was quite
identical, but very different from Stat1 (neuronal-like) and Il1b.
Unlike Cd44 and Ch25h, Stat1 did not seem to response to
RU486 in a dose-dependent manner and Il1b gene expression was
not significantly different among groups (ANOVA). For the latter
transcript, a significant linear trend between induced mRNA levels
and increasing doses of RU486 was reached (p,0.05; trend
analysis). Noteworthy, the cRNA probe used was designed to
hybridize the same target region present in affymetrix gene chips.
The expression pattern of C1qa and Hexb is highly suggestive of
ubiquitous constitutive expression, which was selectively repressed
by the endotoxin in the ipsilateral side of injection (Fig. 4B).
Because LPS-gene profiling indicated repression of the comple-
ment classical pathway [C1qa, C1qb and C1qc downregulation
and Serping1 (C1-Inhibitor) upregulation], we further character-
ized the temporal dynamic of this process (Figure S2).
According to our double labeling procedure, Cd44, Tnfsf9 and
Cd83 are expressed mainly by microglial cells, Lcn2 by endothelial
cells and Saa3 transcript by microglia and few astrocytes. In
contrast, Stat1 is mainly produced by neurons (Figure S3).
The cellular characterization of Cp: a candidate gene
dependent on GR and LPS signaling
As our selection of candidate genes relied on a potential protective
role, we screened genes based on their natural regulation in
presence of an intact LPS and GR signaling. As depicted by the
figure 1D, many genes had the desired behavior and we looked for
those that had been previously linked to neurodegenerative
disorders. We found ceruloplasmin (Cp) that was strongly induced
by LPS (neuroprotection) and completely inhibited by the GR
blockade (a neurotoxic condition). Cp gene encodes a protein with
ferroxidase activity and loss of function mutations in this gene
leads to accumulation of iron and human neurodegenerative
disease (see discussion). We then postulated that induction of Cp
might be a potent neuroprotective mechanism during acute
inflammation.
The regulation of that transcript was quantified by different
complementary approaches. Quantification of in situ hybridization
data indicated that RU486 significantly prevented LPS-induced
Cp gene expression, but only at the higher dose tested (Fig. 5A, B).
Nevertheless, this effect of RU486 was confirmed with a lower
dose by quantitative RT-PCR (Fig. 5C). In addition, figure 6D
shows that the four different probe sets used in the gene chip
generated the same data, which all together provide very solid
evidence that GR blockage is able to prevent LPS-induced Cp
Inflammation & Neuroprotection
PLoS ONE | www.plosone.org 2 March 2007 | Issue 3 | e310Figure 1. Gene profiling of CNS LPS response in presence or absence of functional GR signaling. (A) Treatment schedule of animals. (B and C)
Schematic representation of the injection site and brain area dissected for RNA isolation, respectively. (D) A 2-contrast plot of genes selected as
differently expressed in ipsilateral side when LPS injection was performed in mice pre-treated or not with RU486. The abscissa axis represents the
difference (contrast) between LPS/RU486 treatment and LPS single treatment (RMA expression levels); ordinate axis represents the LPS vs. Saline
contrast. Red dots represent ipsilateral contrast value; green dots, represent contralateral contrast values. Genes highlighted in the diagram were
selected for validation experiments. Dashed lines: 30% fold-change. (E) Similar to ‘‘D’’, but in regard to contralateral side. (F) Representation of the
gene expression behavior associated with RU486 effects on LPS-induced changes, defining how these groups of genes are described in the text.
Abbreviations: AP, antero-posterior; contra, contralateral; DV, dorso-ventral; i.p., intra-peritoneal; ipsi, ipsilateral; i.s., intrastriatal; L, lateral.
doi:10.1371/journal.pone.0000310.g001
Inflammation & Neuroprotection
PLoS ONE | www.plosone.org 3 March 2007 | Issue 3 | e310Figure 2. Functional classification and biological relevance of the differently expressed genes. The plot showing significant biological processes
(hypergeometric distribution) associated with six different lists of differently expressed genes (LPS upregulated, LPS upregulation exacerbatedb y
RU486, LPS upregulation prevented by RU486, LPS downregulated, LPS dowregulation prevented by RU486 and RU486 main effect). Hierarchical
clustering of the Gene Ontology nodes was performed as described in text S1. A color/intensity code assigns number of genes and p-value for each
biological process associated with the lists’ heat map.
doi:10.1371/journal.pone.0000310.g002
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PLoS ONE | www.plosone.org 4 March 2007 | Issue 3 | e310geneexpression.Wethendeterminedthe type ofcells that synthesize
this protein during an acute immune challenge and found co-
localization of Cp mRNA with IBA1-, GFAP- and CD31-
immunoreactive (ir) cells (Fig. 5E). Confocal laser microscopy was
also used to accurately distinguish the different types of cells with
positive Cp-ir signal. As depicted by the figure 5F, Cp protein
strongly co-localized with endothelial cells and IBA1-postive
microglia and co-localization with GFAP-astrocytes was rare.
MAC-2 is frequently used as a marker of a subtype of activated
microglia, but it failed to express Cp (Fig. 5F). It is worth mentioning
that the shape of MAC-2-positive cells was quite different from that
of IBA1-positive microglia (Figure S4), suggesting the possibility that
Cp is produced by the resident ramified microglia (IBA1) and not
amoeboid-like or infiltrating myeloid cells (MAC-2).
Figure 3. Bimodal RU486 effect on CNS inflammation as demonstrated by APRs and genes only responsive to LPS upon GR-antagonism. (A) Dark-field
photomicrographs showing hybridization signals of the specified transcripts from mice that received saline or, LPS or, LPS/RU486 combined
treatments. (B) Semi-quantitative analysis of mRNA levels [optical density (O.D.)] in mouse brains 12 h after the intracerebral infusions. Absence (-) or
presence (+) of LPS or increasing doses of RU486 is indicated. Quantification methods may vary among transcripts; see ‘‘Experimental Procedures’’
section. Results represent means 6 SEM of 3–5 mice per group. One-way ANOVA followed by a Tukey’s HSD multiple comparison test: significantly
different (* p,0.05, ** p,0.01, *** p,0.005) from the saline-injected group; significantly different (# p,0.05) from the LPS-treated group.




PLoS ONE | www.plosone.org 5 March 2007 | Issue 3 | e310Figure 4. Validation of genes upregulated or downregulated by LPS in a glucocorticoid-dependent manner. (A) Representative examples of coronal
sections depicting LPS induced changes in gene expression of the indicated transcripts. (B) Semi-quantitative analysis of mRNA levels (O.D.) in mouse
brains 12 h after the intracerebral infusions. One-way ANOVA followed by a Tukey’s HSD multiple comparison test: significantly different (* p,0.05, **
p,0.01, *** p,0.005) from the saline-injected group; significantly different (# p,0.05, ### p,0.005) from the LPS-treated group. Abbreviations:
Ipsi, ipsilateral; LV, lateral ventricle; Pir, piriform cortex.
doi:10.1371/journal.pone.0000310.g004
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PLoS ONE | www.plosone.org 6 March 2007 | Issue 3 | e310Figure 5. Characterization of ceruloplasmin (Cp) expression following an acute innate immune challenge. (A) Hybridization signals of Cp riboprobe on
brain sections of saline-, or LPS-, or LPS/RU486-treated mice, sacrificed 12 h after the intrastriatal injection. (B) Semi-quantitative analysis of Cp mRNA
levels (O.D.) depicted in ‘‘A’’. (C) Results of quantitative reverse-transcriptase PCR (qPCR). (D) RMA expression levels of four different probe sets to
detect Cp transcript selected according to a significant LPS effect. (E) Representative microphotographs of labeling experiments combining
immunohistochemistry with in situ hybridization. Silver grain signals (Cp mRNA) overlap IBA1-, GFAP- and CD31-positive cells. (F) Confocal microscopy
results showing co-localization of CP protein with CD31-, IBA1- and GFAP-positive cells, but not with MAC-2-positive cells, in brain sections from
animals sacrificed 24 h after LPS challenge. Dark arrowheads: co-localization of silver grains with immunolabeling brown staining. Empty white
arrows: co-localization determined by confocal laser scanning. Full white arrows and white arrowheads were used to identify cell types that failed to
show convincing co-localization. One-way ANOVA followed by a Tukey’S HSD multiple comparison test: significantly different (** p,0.01, ***




PLoS ONE | www.plosone.org 7 March 2007 | Issue 3 | e310Figure 6. Ceruloplasmin regulates brain iron levels during inflammation and confers neuroprotection. (A) Cp+/+, +/- or -/- mice were sacrificed 2 days
after LPS infusion and brain sections stained for Iron III (Perls’ staining). (B) High magnification of iron labeling (representative brain sections from
Cp-/-mice sacrificed 2 or 5 days after LPS infusion). (C) Surface analysis to determine extent of iron deposition. (D) Fluoro-Jade B (FJB) staining was
performed in brain sections from Cp+/+, +/- and -/- infused with LPS or saline. Volumetric analysis was performed by stereological procedure. (E)
Representative dark-field picture of adjacent brain sections hybridized with Tlr2 cRNA probe in LPS treated mice 2 days after infusion. (F) Semi-
quantitative analysis of Tlr2 mRNA hybridization signal. (G) Representative sections hybridized with Plp cRNA riboprobe to detect regions lacking
signals (demyelinated area). These panels show two different coronal levels (cannulae track level and a section distal to the site of injection). (H)
Surface analysis of demyelinated area. (I) and (J) are representative microphotographs of Sudam Black B (SBB) stained sections from Cp+/+ and -/-
mice sacrificed 2 days after LPS infusion, as indicated. Statistical analysis was performed via a two or three-way ANOVA followed by a Bonferroni’s
multiple comparison test when applicable. ‘‘a’’, significant genotype effect (p,0.05), significant time effect (p,0.01), significant treatment effect
(p,0.001), Cp-/-significantly different from Cp+/+ (p,0.01) and Cp+/- (p,0.05). ‘‘b’’, significant genotype effect (p,0.01), Cp-/- statistically different
from Cp+/+ (p,0.005). ‘‘c’’, significant interaction between treatment and time factors (p,0.01), LPS treatment 2 days statistically different from LPS
5 days (p,0.001). ‘‘d’’, significant interaction between treatment and genotype effect (p,0.05), significant time effect (p,0.001), in the LPS treated
group Cp-/- was statistically different from Cp+/+ ({ p,0.005) and from Cp+/- ({ p,0.01). Abbreviations: cc, corpus callosum; CPu, caudate putamen;
ct, cannulae track; Cx, cortex; LV, lateral ventricle.
doi:10.1371/journal.pone.0000310.g006
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LPS-injected mice at time-point 2 days post injection. Such
a staining largely declined 3 days later suggesting a rapid and
transient secretion of this protein during inflammation. As
expected, Cp-/-mice failed to exhibit any CP-ir signal following
similar treatments (Figure S5).
Neuroprotective role of Cp during an acute
inflammatory reaction
Due to the involvement of Cp in iron metabolism, we measured
iron accumulation in the mouse brain following a single in-
tracerebral LPS bolus. As depicted by the figure 6A, B and C, LPS
was able to increase iron III deposition in the ipsilateral side of
injection in both Cp+/+ and Cp-/-mice. Interestingly, the cells
containing iron III had a different morphology over time, being
frequently round at 2 days post-injection and changing to
a ramified shape at 5 days (Fig. 6B). Cp-deficient mice had
a dramatic increase in iron III deposits following LPS adminis-
tration, especially at time-point 2 days. Accentuated iron accu-
mulation in Cp-/-animals seems to correlate with neurodegenera-
tion in this genotype, at least as evaluated by the fluorescent
marker Fluoro Jade B (FJB, Fig. 6D).
The gene encoding Tlr2 is induced in microglia during innate
immunity, but no significant change was found between both groups
of mice treated with the endotoxin (Fig. 6E, F), indicating that
microglia reactivity to LPS is Cp independent. Thereafter, we
evaluated whether Cp may play a role in protecting the CNS white
matter from an acute inflammatory challenge. Surface analysis of
Proteolipid protein 1 (Plp1) mRNA levels rapidly decrease during
demyelination or myelin-associated cell death [11]. Figure 6 (panel
G and H) shows representative examples of such demyelinating
processes in Cp-/-and not in Cp+/+or Cp+/-mice. These data were
corroborated by the myelin SBB staining (Fig. 6I, J), which all
together provide evidence that the endotoxin can indeed provoke
demyelination, but only in mice that bear a mutation in the Cp gene.
Role of Cp in Streptococcus pneumoniae-induced
meningitis
Since blood vessels are strategically positioned to produce Cp
protein during systemic infection, we evaluated whether this APR
modulates gene expression in vascular-associated elements during
meningitis. S. pneumoniae infection was used to test a possible role of
Cp in this context. No difference was found in the survival curves
of the three genotypes following S. pneumoniae inoculation (Fig. 7A).
Nevertheless, Cp was strongly induced in brain blood vessels of
infected Cp+/+ mice (Fig. 7B). We then determined Nfkbia (IkBa)
and Selp (P-Selectin) gene expression; Nfkbia expression is
a general index of NF-kB activation, which seems quite similar
in the cerebrovascular system of the three genotypes (Fig. 7C, F).
In contrast, Selp transcript was mainly induced in large blood
vessels (Fig. 7 D, E, F) and its expression level was higher in the
brain of Cp-/-mice. The time point 48 h was used for this
comparison, because the variability among mice was high from
day 3 and the number of animals that exhibited clinical signs was
irregular between the genotypes and this variability complicated
the interpretation of the results. Forty-eight h after inoculation, the
number of animals with clinical signs was equivalent in both Cp+/
+ (n=6) and Cp-/-(n=7) group, but not in the group of Cp+/-mice
(n=3). Since the highest variance was associated with Cp+/-
genotype, we removed this group from the statistical analysis to
avoid misrepresentation and substantial reduction of power. In this
regard, Selp mRNA levels were significantly different between
Cp+/+ and Cp-/-according to student’s t-test (p,0.05), but not
Figure 7. Modulation of cerebro-vascular response by ceruloplasmin
during early phases of pneumococcal infection. (A) Survival curves of
Cp+/+, +/- and -/- following inoculation with S. Penumoniae (2 week
follow up). (B) Ceruloplasmin protein immunoreactivity at the vascular
level in the hindbrain of a Cp+/+ infected mouse; Cp-/- mice was used as
control for the primary antibody. (C) Dark-field photomicrographs
showing representative hybridization signals of Nfkbia or Selp ribop-
robes on hindbrain sections of Cp+/+ or -/- mice killed at the early phase
of infection (36–48 h post-infection). (D) High magnification photo-
micrographs depicting the expression pattern of Selp mRNA associated
with large blood vessels and not in cells lining the meninges or the
ventricle. (E) Semi-quantitative analysis of Nfkbia and Selp mRNA levels
O.D. Student’s t-test was used to compare Cp+/+ and Cp-/- means (see
text for details); * p,0.05. Abbreviations: bv, blood vessel; Cb,
cerebellum; IC, inferior colliculus; m, meninges.
doi:10.1371/journal.pone.0000310.g007
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less, a significant linear trend between Selp mRNA levels and Cp
deficiency was reached (p,0.05) when assigning 0, 1 and 2 values
to Cp-/-, +/-and+/+genotypes, respectively. These statistical tests
did not reveal any significant changes in Nfkbia mRNA levels
among two or three genotypes.
DISCUSSION
New roles for GR signaling during acute
neuroinflammation
The capacity of GR to repress NF-kB/AP-1 activity and gene
transcription is believed to be a key intracellular process mediating
the powerful anti-inflammatory properties of synthetic and
endogenous GCs. Such a mechanism was elegantly explored by
gene profiling using cell-culture system and the GR agonist
Dexamethasone (Dex) [12]. Surprisingly we found that blocking
endogenous GR signaling exacerbated the expression of a small
and restricted set of inflammatory genes induced by LPS in the
CNS. Curiously, most of these upregulated genes were found in the
contralateral side, probably reflecting saturation in the ipsilateral
side and spreading to distal sites. Genes with this behavior belong to
the chemokine network and then to an increased recruitment of
inflammatory cells. Interestingly, the effects of RU486 and LPS
was found for genes linked to adaptive immunity Cd83 and Tnfsf9
[13,14]. Ablation of glucocorticoid signaling also intensified
induction of transcription regulator Litaf and Zfp36 and the
regulator of JAK-STAT pathway Pim-1 and Socs3.
Therefore our results do not rule out the possibility that GR
antagonism increases the inflammatory reaction in the CNS,
especially at later time-points. These data do suggest that genetic
profile is no longer respected in the absence of GR signaling on the
cerebral immune system. Although the effects of GRs on the
regulation of genes encoding APRs were expected [15], this was
not the case for those implicated in host defense. In this regard,
a recent study has demonstrated that combination of Dex
treatment can lead to an unpredicted genetic response to LPS
[16] or enhance expression of immune genes in peripheral blood
monuclear cells [17]. Hence, it is very likely that the role of GCs
on expression of inflammatory genes depends on various factors,
including cell/tissue type, pharmacological strategy and use of in
vivo or in vitro models. Some of our results may be in sharp contrast
to those previously reported because the paradigm used here to
access the role of endogenous glucocorticoids does not block the
inflammatory process.
Our gene profiling data indicated that endogenous GCs are
required to coordinate the ability of LPS for inducing expression of
genes involved in the viral and interferon response. These include
components of viral dsRNA sensing pathway Ifih1 (MDA-5), Ikbke
(iKK/IKKe) and Irf7 [18]. In addition, we have identified a set of
genes that participate in the antiviral network of interferon response
initiated by Stat1/2, namely Isgf3g (IRF-9), Oas1a and Eif2ak2
(PKR) [19]. Expression of genes encoding GTPases was also
dependent on GR signaling. Although the functions of these
molecules remain largely unknown, a role for Irgm (Ifi1/LRG-47)
was recently described in the generation of large autolysosomal
organelles that eliminate intracellular Mycobacterium tuberculosis [20].
Therefore, our results may help explaining why Dex treatment is
beneficial in tuberculosis meningitis, which is not associated with
attenuation of the immune response [21]. In addition, a GC
replacement therapy has been shown to have beneficial effects in
a contextofsepticshock[22].Importantly,impaired geneexpression
by GR interference may increase infection susceptibility, which was
recently found in few cases of RU486-treated women [23].
Although GR signaling is necessary to support innate immune
response gene expression, our results should not be interpreted as
a newly described pro-inflammatory role of GCs. Many recent
studies pointed that GC exposure may increase CNS inflamma-
tion and Sorrells and Sapolsky suggested a conciliatory manner
to interpret both anti- and pro-inflammatory effects of GCs
based on early, delayed, acute or chronic regimen [24]. We
suggest careful attention in order to dissociate gene expression
from inflammation. Several genes that depend on GR to be
induced by LPS play important roles in terms of cell
differentiation, acute phase response, extracellular matrix orga-
nization and interferon response, all of which potentially helping
to resolve inflammation rapidly. The lack of this gene subset in
association with the exacerbated expression of genes identified
here as GR repressed (chemokines, Tnfsf9, Cd83, etc.) can
clearly result in increased inflammation at latter time-points and
in the emergence of a detrimental microglial/macrophage
phenotype.
It is interesting to note that many regulated genes that exhibited
a particular profile (i.e., RU486 prevented their downregulation to
LPS) are related to brain development and not necessarily to
myeloid functions. These data suggest alternative mechanisms
underlining the actions of GC and TLR4 signaling on gene
repression in the CNS. Our factorial design also allowed us to
report a list of genes that follows a GR-blockage main effect,
revealing genes that respond to RU486 and are not changed by
the inflammatory reaction.
Anatomical findings regarding GR-modulated
inflammatory gene expression
As depicted by the figure 3 and 4, a very distinct anatomical
distribution was found for most regulated genes by the treatment
combining RU486 to LPS. Such finding, which is further
illustrated in co-localization experiments (Figure S3), implies that
these transcripts may play very different roles despite having
similar regulatory processes. While it is possible to infer an
immune role for Tnfsf9 and Cd83 in myeloid cells, the role of
Gem in cells lining the meninges must be further explored.
Serpina3n (a mouse homologue of a1-antichimotrypsin), Cd44,
and Ch25h expression levels were also verified, because of the
novelty of the gene array results and their possible involvement in
the physiopathology of Alzheimer’s disease [25–27]. Unbalance of
the inflammatory and GC response is also a feature of the disease
[6,28]. Stat1 induction in neurons was startling, because it is
usually a gene related to viral and adaptive immune responses [29]
and here we found a selective neuronal transcriptional activation
during innate immunity. The lack of Il1b induction following
RU486/LPS administration was also quite intriguing, although
increased expression of this cytokine following GC administration
has been reported [30]. Careful interpretation must be taken
regarding this particular transcript, because in situ hybridization
could not clearly corroborate this result.
The endotoxin was able to downregulate a number of genes in
a GR-dependent manner. These include C1qa and Hexb genes,
but the meaning of their localized suppression during neuroin-
flammation has yet to be determined. Inhibition of the classical
complement pathway could be a natural mechanism to avoid
a precipitated antibody mediated cell lysis, whereas Hexb may
have uncharacterized immune properties modulating neuronal
functions. Indeed, Hexb gene disruption in mice leads to
neurological deficits, which can be partially prevented by the
transplantation of bone marrow stem cells taken from wild type
mice [31].
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homeostasis and brain protection
The gene profiling results clearly pointed out that APR gene
induction was a prominent feature of the ability of GRs to
modulate the inflammatory transcriptional programs. The role of
APRs during infection is not well understood, but a subset of genes
is implicated in iron homeostasis. For instance, Lcn2 plays an
important role in iron acquisition during infection [32]. Because
iron unbalance is implicated in demyelinating and neurodegener-
ative diseases [33,34] and aceruloplasminemia leads to brain, liver
and pancreas iron accumulation with concomitant neuronal
damages [35,36], Cp is a putative candidate to mediate
neuroprotection during inflammation. Surprisingly, murine mod-
els of aceruloplasminemia accumulate iron, but they do not
develop the neurological features of the disease [37,38]. Iron
accumulation in human disease and murine models led to the
inference that Cp is important to release iron from the cellular
pool, especially mediated by a membrane glycosylphosphatidyli-
nositol-form of this ferroxidase [39]. Conversely, it has been
suggested that extracellular Cp mediates cellular iron uptake and
iron absorption during stress [40]. Our findings suggest that an
acute inflammatory reaction leads to tissue iron accumulation that
persists through the course of the immune challenge. Cp is not
required for LPS mediated iron (III) deposition, but this protein
seems to play a role avoiding precipitated iron unbalance.
The physiological relevance of this process has yet to be
determined, but it could be related to limit the iron uptake by
bacteria or to avoid an exacerbated accumulation of reactive iron
(II) levels. The data that LPS caused CNS injury in Cp-/-mice and
not their control littermates are quite interesting, because they
underline the critical neuroprotective role of Cp in an in-
flammatory context. We propose that Cp produced by microglial
cells is released to the extracellular space for controlling iron
homeostasis in this critical period, when white matter elements are
more vulnerable. Hence, these findings support an important new
role for Cp in mediating neuroprotection in the course of an acute
innate immune process. Such neuroprotective properties of Cp are
not associated with changes in microglial reactivity to LPS.
We also observed that Cp is highly expressed in cells lining the
blood vessels. In consequence, it was attractive to test the
hypothesis that Cp could be a mediator of barrier function,
protecting the brain against circulating pathogens or potentially
damaging molecules derived from their infection. S. Pneumoniae is
a leading cause of meningitis worldwide. It is proposed that high
levels of bacteria in the blood targets the endothelium in order to
reach brain compartments [41]. We then used a model of
peripheral inoculation passive of meningitis. Although no changes
in terms of susceptibility were observed in the course of infection
among genotypes, Cp-/-exhibited a very different vascular re-
activity to the circulating bacteria. In fact, Cp deficiency was
associated with a robust expression of Selp transcript in large
blood vessels and arteries. Selp controls key events related to
leukocyte cell recruitment and this adhesion molecule is a de-
terminant modulator of vascular permeability to bacterial
elements [42]. This highlights another new function of Cp in
stabilizing neurovascular responses in the course of pneumococcal
infection.
Concluding Remarks
Endogenous GCs play a critical role for modulating the innate
immune response in the CNS. Ablation of GR signaling
exacerbated the expression of a small subset of genes, which are
implicated in cell recruitment and prolonged immune activity.
Surprisingly, expression of many genes related to host defense
were critically impaired upon RU486 treatment, a mechanism
that could explain unusual bacterial infections in individuals taking
this compound as abortion pill and the beneficial effects of an
acute therapy with GCs. This gene profiling experiment led us to
investigate the role of Cp in the course of an acute LPS challenge.
Experiments using Cp-deficient mice generated exciting data
regarding the ability of acute-phase proteins to make the difference
between cell survival and death during a natural and timely
sensitive innate immune reaction in the CNS.
MATERIALS AND METHODS
Animal experimentation
Adult male C57Bl/6 (body weight, 25–29 g; Charles River
Canada, St. Constant, Que ´bec, Canada) were acclimated to
standard laboratory condition. Ceruloplasmin-deficient mice
(Cp-/-) in C57Bl/6 background [38] were backcrossed two rounds
with female C57Bl/6 mice. The backcrossed heterozygote mice
(Cp+/-) were used to generate Cp+/+, +/- and -/-mice. These mice
were genotyped by PCR of DNA isolated from ear punching.
Animal breeding and experiments were conducted according to
Canadian Council on Animal Care guidelines, as administered by
the Laval University Animal Care Committee. Efforts were made
for minimizing animal number utilization; 3 to 6 animals per
group were used in each experimental group, except for infection
protocol (19 to 20 mice per group).
Inflammatory treatment
In protocols for a comparative study of the effects of endogenous
GCs, C57Bl/6 mice received an i.p. injection of vehicle (DMSO-
50 ml) or RU486 (50 mg/kg b.w.) and were submitted to surgery
4 h later. Just after the surgery the animals received a second i.p.
injection of vehicle or RU486 to guarantee high brain levels of the
drug. In a second protocol mice received different doses of RU486
(5, 50 and 200 mg/kg b.w.) in similar conditions in order to test
dose-dependent effects. The mice receiving intraparenchymal
injections were anesthetized with a mixture of ketamine and
xylazine and placed in a stereotaxic apparatus (David Kopf
Instruments). The right caudate putamen was reached, using
a small cannula (28 gauge; Plastic One) at the coordinates 0.0 mm
anteroposterior, 22.0 mm lateral, and 23.0 mm dorsoventral
according to a mouse brain atlas [43]. The coordinates were
selected on the basis of previous experiments showing a robust
hybridization signal and reliable pattern of cytokine gene
expression over the ipsilateral cerebral cortex, hippocampus,
corpus callosum and basal ganglia following a single bolus of
immune ligand. The animals received an infusion of either sterile
pyrogen-free saline (1 ml) or LPS (2.5 mg; from Eschericia coli;
serotype O55:B5; Sigma L2880) over 2 min by means of
a microinjection pump. Animals were killed 12 h after the
injection for the microarray gene profiling and validation
experiments. Another group of Cp-deficient mice and respective
controls (+/-, -/-) were killed 2 and 5 days after intrastriatal (IS)
infusion with saline or LPS.
For gene array and qPCR assay, mice were anesthetized under
isofluorane and blood was drawn via cardiac puncture before head
decapitation. Brains were removed rapidly from the skulls and
placed in cold phosphate buffered saline (PBS) solution. A brain
region defined by dashed lines in figure 1 (limited at plane
anteroposterior +1.5 to 21.5 and dorsoventral 24.0) was
dissected, separated in ipsilateral and contralateral sides, and
quickly immersed in liquid nitrogen. The tissue was stored at
280uC until RNA extraction was performed. The dissected area
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and was restricted to avoid dilution of the sample with RNA from
non-relevant brain regions.
For in situ hybridization histochemistry, histology and immuno-
labeling, animals were deeply anesthetized via an intraperitoneal
injection of a mixture of ketamine hydrochloride and xylazine and
then rapidly perfused transcardially with 0.9% saline, followed by
4% paraformaldehyde in PBS, pH 7.6, at 4uC. Brains were
removed rapidly from the skulls, postfixed for 2–4 d, and then
placed in a solution containing 20% sucrose overnight at 4uC. The
frozen brains were mounted on a microtome (Reichert-Jung) and
cut into 25-mm coronal sections. The slices were collected in cold
cryoprotectant solution and stored at 220uC.
Streptococcus Pneumoniae infection
A virulent S. Pneumoniae strain capsular type 6A DBL6A was used
in an experimental model of pneumococcal infection passive of
meningitis. The mice (n=19 for Cp+/- and -/-; n=20 for Cp+/+)
were anesthetized and received an i.p. injection of the working
suspension (50–100 C.F.U./ml) in a 100 ml volume [see
supplementary materials and methods (Text S1) for bacteria
suspension preparation]. Animals were assigned to receive the
injections in a random manner. Whenever mice presented clinical
and/or dehydration signs, Ringer’s lactate and/or buprenorphine
were administrated to relief discomfort. Once animals showed
clearly signs of irreversible illness or neurological impairment, they
were sacrificed by cardiac perfusion as described above except that
PFA was prepared in 0.1 M borax buffer, pH 9.5.
RNA isolation and Oligonucleotide array
The RNA was isolated using Trizol reagent (Invitrogen) following
manufacture’s protocol and 10 mg of total RNA was used for
cDNA synthesis. Converted cDNA using a T7-oligo-d(T)24
primer were used to generate biotinylated cRNA, the latter was
fragmented before hybridization, as described in [44]. The quality
of total RNA, cDNA synthesis, cRNA and cRNA fragmentation
were all monitored by micro-capillary electrophoresis (Bioanalizer
2100, Agilent Technologies). cRNA probes were hybridized onto
MOE403A mouse Genechip (Affymetrix) and processed using an
Affymetrix GeneChip Fluidic Station 400. Staining was per-
formed with streptavidin-conjugated phycoerythrin (SAPE) fol-
lowed by amplification with a biotinylated anti-streptavidin
antibody and by a second round of SAPE solution. The
GeneChips were scanned using an Agilent GeneArray Scanner
(Agilant Technologies).
Oligonucleotide array statistical analysis
After careful quality control to discard abnormal samples
according to multiple evidences (4 chips from different groups
were removed), a total of 37 chips were used for oligonucleotide
array analysis [one chip per biological sample; 8 groups
(contralateral dmso/saline, dmso/LPS, RU486/saline, RU486/
LPS and ipsilateral dmso/saline, dmso/LPS, RU486/saline,
RU486/LPS) with 4–6 biological replicates each]. Expression
values from the CEL files generated from scanning were obtained
using RMA algorithm [45], available at http://www.bioconduc-
tor.org. The expression values were also inspected with Gene-
Spring software (Silicon Genetics). Statistical analysis was
performed considering a factorial linear model according to the
methods implemented in Limma package [46] (R project packages
are available at http://www.cran.r-project.org). For details on
differential gene expression and Gene Ontology (GO) analysis,
please refer to text S1. The data discussed in this publication have
been deposited in NCBIs Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and are accessible through
GEO Series accession number GSE6509.
Quantitative Polymerase Chain Reaction (qPCR)
Real-time RT-PCR was performed as described in [47], for
further details refer to text S1.
cRNA probes and in situ hybridization
Plasmids were linearized and the sense and antisense
35S-labeled
riboprobes were synthesized as described before ([48], refer to text
S1 for details). Hybridization histochemical localization of the
different transcripts was performed on every 6th or 12th section of
the entire rostrocaudal extent of each brain. The sections were
exposed at 4uC to x-ray films (Biomax; Kodak). The slides were
thereafter defatted in xylene, dipped into NTB-2 nuclear emulsion
(Kodak).
Combination of immunohistochemistry with in situ
hybridization
Immunohistochemistry was combined with the in situ hybridiza-
tion histochemistry protocol to determine the types of cells that
express Cd44, Cd83, Cp, Lcn2, Saa3, Stat1 and Tnfsf9 transcripts.
Anti-CD31 was used to stain the endothelial cells of the
vasculature, whereas anti-ionized calcium binding adapter mole-
cule 1 (IBA1), anti-glial fibrillary acidic protein (GFAP) and anti-
neuron specific nuclear protein (NEUN) labeled cells of myeloid
(macrophages and microglia), astroglial and neuronal lineages,
respectively. Dual labeling was performed as described in [48]; rat
anti-mouse CD31 (BD Biosciences Pharmingen), rabbit anti-
human IBA1 (Wako), monoclonal anti-mouse GFAP (Chemicon)
and monoclonal anti-mouse NEUN (Chemicon) were diluted at
1:500, 1:1500, 1:1000 or 1:2000, respectively.
Iron, Myelin and, FluoroJade B (FJB) staining
Iron (III) staining was performed on free-floating sections as
a described improved method for Perls’ stain [49]. Specificity of
dark brown deposits was verified in replacing potassium
ferrocyanide for potassium ferricyanide [for iron (II) detection],
which failed to reveal such staining. Myelin content and
byproducts were determined via Sudan Black B (SBB) staining,
whereas neuronal cell death was investigated by means of the
Fluoro-Jade B (FJB) method, as previously described [9,11].
Immunohistochemistry and Immunofluorescence
Immunolabeling was performed on free-floating sections following
standard procedures detailed in text S1. Cp immunohistochem-
istry staining specificity was verified using brain sections of Cp
deficient mice. Double immunofluorescence staining was per-
formed in sequential manner; primary antibody against Cp
detection with Alexa488-conjugated goat anti-rabbit was followed
by incubation of primary antibodies against CD31, GFAP, IBA1,
or MAC-2 that were detected with immunoglobulin antibodies
conjugated to Cy3.
Photomicrographs were taken with the same exposure time
using a digital camera (QIMAGING) mounted directly on
a microscope (Nikon Eclipse 80i). Confocal laser scanning
microscopy was performed with a BX-61 microscope equipped
with the Fluoview SV500 imaging software 4.3 (Olympus America
Inc). Confocal images were acquired by sequential scanning using
a two-frame Kalman filter and a z-separation of 1 mm.
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Semi-quantitative analyses of hybridization signals were per-
formed as described previously [11], but differential (ipsilateral–
contralateral) optical density (O.D.) was not used for transcripts
that had signals extending largely to the contralateral side. The
average O.D. after background correction was used for these
particularly widely spread mRNAs. Genes with restricted,
constitutive or unusual pattern of expression were quantified
accordingly to their characteristics to avoid miscalculation or
underestimation of signals. Samples from S. pneumoniae infection
protocol were analyzed at the level of hindbrain. Quantification of
area without Plp1 transcript signal (demyelinated regions and
areas associated with lesions) was performed as previously
described [11].
Estimation of Area and Volume by Stereology
Stereological analysis was performed as previously described [11].
Systematically sampled sections were stained for iron III or
Fluorojade B staining. The area associated with dark Iron III
deposits was traced and the total area values for each sample were
acquired using Neuroexplorer software (MicroBrightField). Vol-
ume of brain regions showing FJB-positive staining was estimated
by the Cavalieri method (50-mm point grid) using Neurolucida
Stereo Investigator software (Microbrightfield).
Image processing
Photomicrographs were processed to enhance contrast and image
quality using Adobe Photoshop 8 (Adobe Systems) and were
assembled using Adobe Illustrator (Adobe Systems). The image
edition was kept to a minimum to avoid artifacts. Pictures
representing different groups received equivalent image treatment.
Statistical Analysis
Comparison of group means was performed using an one-way
ANOVA followed by a Tukey’s HSD procedure as post hoc
multiple comparisons test. Two or three factor ANOVA was
performed using Bonferroni’s correction when applicable and also
according to presence or absence of interaction between factors.
Student’s t-test was applied for comparison between two groups
according to homogeneity of variances. All the analyses were
carried out with SPSS software version 11.0, except for Logrank
test and Logrank test of trend to compare survival curves, which
were performed using Prism 4 software.
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